Sarepta Therapeutics is pausing shipments of its gene therapy for muscular dystrophy following several patient deaths that ...

US stocks remain narrowly mixed amid more earnings reports. Investors are looking for impact of Trump's tariffs. Chip stocks weigh on Nasdaq, S&P 500.